Ernst & Young LLP
Global Biotechnology Center
200 Clarendon Street
About Ernst & Young LLP
Ernst & Young pioneered professional services in support of biotechnology and is recognized as the leader in serving the industry. Since the industry's inception, Ernst & Young has consistently met the changing business needs of biotech companies, helping them address a range of critical business issues including:
- Product development and commercialization - Strategic asset management - Regulatory strategy and compliance - Financial planning - Information systems and technology - Business performance improvement - International business development - Business planning - New venture development - Corporate development - Strategic partnering - International tax strategy - Transactions - Corporate finance - Worldwide accounting, auditing, and tax
Ernst and Young biotechnology service teams are part of an extensive global network of professionals with industry-specific backgrounds. Our service philosophy is based on the effective integration of the people, processes, and technology for enterprise-wide improvement.
Ernst & Young is committed to supporting companies within each phase of the life sciences industry life cycle. Whether yours is a mature company or a visionary start-up, we can help. Our long-standing commitment to life sciences companies, coupled with our technical services capabilities, makes Ernst & Young the firm of choice for the biotechnology industry.
136 articles with Ernst & Young LLP
EY Announces Dr. Uma Sharma of MMS Holdings as an Entrepreneur Of The Year® 2020 Michigan and Northwest Ohio Award Finalist
EY Announces Dr. Uma Sharma of MMS Holdings as an Entrepreneur Of The Year ® 2020 Michigan and Northwest Ohio Award Finalist Celebrating the unstoppable entrepreneurs whose ambitions transform our world CANTON, Mich.--( BUSINESS WIRE )-- Ernst & Young LLP (EY US) today announced that Founder and Chief Scientific Officer Uma Sharma, PhD of MMS Holdings was named an Entrepreneur Of The Year ® 2020 Michigan and Northwest Ohio Award finalist. No
SPR Therapeutics’ CEO Maria Bennett Named as an Entrepreneur Of The Year® 2020 East Central Award FinalistCelebrating the unstoppable entrepreneurs whose ambitions transform our world
Ernst & Young LLP (EY US) today announced that Maria Bennett, President, CEO and Founder of SPR Therapeutics, Inc. ® was named an Entrepreneur Of The Year ® 2020 East Central Award finalist. Now in its 34th year, the Entrepreneur Of The Year program honors entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they build and sustain successful businesses that transform our world. Bennett was selected as o
EY Announces Steve Sidel of Mindoula as an Entrepreneur Of The Year® 2020 Mid-Atlantic Award Finalist
Ernst & Young LLP announces Steve Sidel, Founder and CEO, Mindoula, is an Entrepreneur Of The Year® 2020 Mid-Atlantic Award finalist.
EY Announces Florian Wegener of ZAGENO as an Entrepreneur Of The Year® 2020 New England Award Finalist
Celebrating the unstoppable entrepreneurs whose ambitions transform our world
Ernst & Young LLP announced that Justin Bellante of BioIQ was named an Entrepreneur Of The Year® 2020 Southeast Award finalist.
McDermott Convenes Leading Heath Care and Life Sciences Investment Professionals and Managers to Share Innovation, Collaborative Growth Approaches
Programming at 2019 J.P. Morgan Healthcare Conference January 7 - 9th will help health industry organizations identify game-changing investment and acquisition opportunities and meet emerging challenges head on
Ajay Singh of Slayback Pharma wins Ernst and Young's Entrepreneur Of The Year® 2018 Award in Life Sciences Category in New Jersey
Slayback Pharma today announced that Founder & CEO, Ajay Singh, of Slayback Pharma LLC is the winner of the 32nd Ernst and Young's Entrepreneur Of The Year® 2018 Award in the Life Sciences category in New Jersey.
91% of US health organizations have or plan to undertake a tech adoption initiative in the next 12 months to improve patient experiences
Ernst & Young LLP Names BioMarin CEO Jean-Jacques Bienaime EY Entrepreneur Of The Year 2015 National Award Winner in Life Sciences
New White Paper From BIO, National Organization for Rare Disorders, And Ernst & Young LLP Finds Orphan Drug Tax Credit Is Crucial To Rare Disease R&D
Advanced Cell Technology Announces Paul K. Wotton Ph.D. Recognized As Ernst & Young LLP 2014 Entrepreneur Of The Year™ For New Jersey Region
NPS Pharmaceuticals, Inc.’ President And CEO Dr. Francois Nader Receives Ernst & Young LLP National Entrepreneur Of The Year® 2013 Award In The Life Sciences Category
Ernst & Young LLP Announces Labcyte Inc. CEO and President Mark Fischer-Colbrie and Co-Founder Rich Ellson as the Entrepreneur Of The Year® 2013 Award Winner in Northern California
Ariad Pharmaceuticals, Inc. Chief Executive Officer, Harvey J. Berger, M.D., Recognized as 2013 Ernst & Young LLP Entrepreneur of the Year® in New England